|
On The Fly
| ShowHide Related Items >><< - 07:38 Today
- Dollar Tree sees FY21 store openings of 600
- 02/16/21
- SPAR Group appoints Mike Matacunas as president, CEO
- 02/04/21
- Instacart announces new national delivery partnership with Family Dollar
- 12/07/20
- Dollar Tree CEO sells 12.4K shares of common stock
- 03/02/21
- Nordstrom says overall trends improved sequentially throughout the quarter
- 03/02/21
- Nordstrom says taking actions to 'significantly reduce inventory levels' in Q1
- 03/02/21
- Nordstrom says Q4 digital sales of about $2B represented 54% of business
- 03/01/21
- Nordstrom, Tonal form partnership
- 09:50 Today
- Michaels trading resumes
- 09:19 Today
- Apollo Global to acquire Michaels for $22.00 per share in cash
- 09:14 Today
- Michaels trading halted, news pending
- 03/01/21
- Michaels jumps 10% after NY Times report of private equity interest
- 09:19 Today
- Apollo Global to acquire Michaels for $22.00 per share in cash
- 06:38 Today
- VICI Properties to acquire Venetian Resort's real estate in Las Vegas for $4B
- 06:34 Today
- Las Vegas Sands to sell The Venetian, other Las Vegas properties for $6.25B
- 06:34 Today
- Apollo Global funds to acquire The Venetian Resort and Sands Expo for $2.25B
- 06:38 Today
- VICI Properties to acquire Venetian Resort's real estate in Las Vegas for $4B
- 06:34 Today
- Las Vegas Sands to sell The Venetian, other Las Vegas properties for $6.25B
- 06:34 Today
- Apollo Global funds to acquire The Venetian Resort and Sands Expo for $2.25B
- 03/01/21
- Macau reports February casino revenue up 135.6% to 7.31B patacas
- 06:38 Today
- VICI Properties to acquire Venetian Resort's real estate in Las Vegas for $4B
- 06:34 Today
- Las Vegas Sands to sell The Venetian, other Las Vegas properties for $6.25B
- 06:34 Today
- Apollo Global funds to acquire The Venetian Resort and Sands Expo for $2.25B
- 12/24/20
- VICI Properties enters triple-net lease agreement with EBCI
- 13:47 Today
- Elanco off lows, turns positive after WSJ report of Starboard board nominations
- 02/25/21
- Kindred submits efficacy data to support prophylactic indication for KIND-030
- 02/25/21
- Apria names Michael-Bryant Hicks as EVP, general counsel
- 02/22/21
- Elanco general counsel Michael-Bryant Hicks to depart
- 03/02/21
- ITC to investigate certain cellular devices made by Samsung, Motorola Mobility
- 02/19/21
- Solas OLED announces patent dispute settlement with LG Display
- 01/27/21
- Samsung sees Memory business recovering during H1
- 01/17/21
- Fly Intel: Top five weekend stock stories
- 11:52 Today
- General Motors extends plant shutdowns due to semiconductor shortage
- 02/25/21
- Caterpillar elects Gerald Johnson to board of directors
- 02/17/21
- EU passenger car registrations down 24.0% in January
- 02/16/21
- Berkshire Hathaway buys Verizon, exits Barrick Gold in Q4
- 08:27 Today
- Takeda secures rights to soticlestat from Ovid Therapeutics for $196M upfront
- 12/16/20
- Ovid Therapeutics announces addition to Nasdaq Biotechnology Index
- 12/01/20
- Ovid Therapeutics falls 43% to $3.75 after failed ph.3 trial of OV101
- 12/01/20
- Ovid Therapeutics ph.3 NEPTUNE trial of OV101 does not meet primary endpoint
TAK Takeda Pharmaceutical - 08:27 Today
- Takeda secures rights to soticlestat from Ovid Therapeutics for $196M upfront
- 02/26/21
- Novavax, Takeda finalize license agreement for COVID-19 vaccine in Japan
- 02/26/21
- Takeda to divest type 2 diabetes portfolio to Teijin Pharma for JPY 133B
- 02/24/21
- Takeda provides update on Novavax, Moderna COVID-19 vaccine candidates in Japan
- 03/02/21
- Lyft raises Q1 adjusted EBITDA view to ($135M) from ($150M)-($145M)
- 02/10/21
- GM not planning to partner with rideshare players as EV portfolio rolls out
- 02/09/21
- Lyft jumps 5% to $56.50 per share after Q4 results
- 02/09/21
- Lyft reports Q4 active riders 12,552, down 45.2%
- 05:25 Today
- KemPharm announces FDA approval of Azstarys NDA
- 01/27/21
- KemPharm announces FDA approval of IND for KP879
- 01/14/21
- KemPharm announces presentations on KP415, serdexmethylphenidate
- 12/23/20
- KemPharm announces 1-for-16 reverse stock split
- $41.77 /
-16.03 (-27.73%) - 09:08 Today
- Vir, GSK: DSMB recommends VIR-7831 arm of ACTIV-3 trial be closed to enrollment
- 02/17/21
- GlaxoSmithKline, Vir expand coronavirus collaboration for respiratory viruses
- 02/01/21
- Vir Biotechnology announces publication on SARS-CoV-2 spike protein
- 01/27/21
- Vir Biotechnology trading resumes
- 07:09 Today
- Wendy's says Q1 sales 'off to a strong start'
- 07:08 Today
- Wendy's sees FY21 cash flows from operations: $310M-$330M
- 07:05 Today
- Wendy's reports Q4 global same-restaurant sales growth 4.7%
- 07:03 Today
- Wendy's reports Q4 U.S. systemwide sales growth of 14.2%
- 13:20 Today Wells Fargo
- Dollar Tree stage now set for share recovery, says Wells Fargo
- 02/25/21
- Fly Intel: Pre-market Movers
- 02/25/21 BofA
- BofA double downgrades Dollar Tree to Underperform, sees multiple headwinds
- 02/25/21 BofA
- Dollar Tree downgraded to Underperform from Buy at BofA
- 02/16/21 JPMorgan
- Nordstrom price target raised to $40 from $34 at JPMorgan
- 02/10/21 Gordon Haskett
- Nordstrom upgraded to Buy from Hold at Gordon Haskett
- 01/21/21 Deutsche Bank
- Nordstrom price target raised to $43 from $24 at Deutsche Bank
- 01/14/21 Credit Suisse
- Nordstrom price target raised to $39 from $26 at Credit Suisse
- 15:28 Today Wells Fargo
- Michaels deal with Apollo Global 'a win for shareholders,' says Wells Fargo
- 01/20/21 Morgan Stanley
- Morgan Stanley downgrades Michaels to Underweight, sees 'too much optimism'
- 01/20/21 Morgan Stanley
- Michaels downgraded to Underweight from Equal Weight at Morgan Stanley
- 12/14/20 JPMorgan
- Michaels downgraded to Neutral after recent rally at JPMorgan
- 15:28 Today Wells Fargo
- Michaels deal with Apollo Global 'a win for shareholders,' says Wells Fargo
- 10:02 Today Stifel
- Las Vegas Sands casino sale news 'clearly a positive,' says Stifel
- 01/20/21 Truist
- Athene Holding price target raised to $55 from $48 at Truist
- 01/11/21 Wells Fargo
- Apollo Global price target raised to $55 from $50 at Wells Fargo
- 12:03 Today Roth Capital
- Golden Entertainment shares worth $40 based on Sands deal, says Roth Capital
- 10:02 Today Stifel
- Las Vegas Sands casino sale news 'clearly a positive,' says Stifel
- 02/09/21 Morgan Stanley
- Morgan Stanley says legalized sports betting in Texas this year has 'slim' odds
- 02/08/21
- Fly Intel: Top five analyst downgrades
- 10:02 Today Stifel
- Las Vegas Sands casino sale news 'clearly a positive,' says Stifel
- 02/22/21 Deutsche Bank
- VICI Properties price target raised to $32 from $28 at Deutsche Bank
- 01/26/21 Goldman Sachs
- VICI Properties price target raised to $33 from $27 at Goldman Sachs
- 12/17/20 JPMorgan
- VICI Properties initiated with an Overweight at JPMorgan
- 02/26/21 Barclays
- Judge allows challenge to Elanco's Experior, says Barclays
- 02/26/21
- Fly Intel: Top five analyst upgrades
- 02/26/21 Credit Suisse
- Elanco upgraded to Outperform from Neutral at Credit Suisse
- 12/18/20 Alliance Global Partners
- Kindred Biosciences price target lowered to $9.25 from $10.25 at Alliance Global Partners
- 02/04/21 Craig-Hallum
- Qorvo price target raised to $195 from $160 at Craig-Hallum
- 02/04/21 Craig-Hallum
- Digital Turbine price target raised to $80 from $60 at Craig-Hallum
- 01/29/21 Needham
- Skyworks price target raised to $245 from $200 at Needham
- 01/26/21
- Applied Materials upgraded to Buy at DA Davidson on semicap strength
- 02/19/21 Morgan Stanley
- GM's 'hidden gems' drawing rising investor interest, says Morgan Stanley
- 02/18/21 Citi
- General Motors price target raised to $85 from $70 at Citi
- 02/16/21 Wedbush
- Wedbush expects Apple to announce formal EV partnership in 2021
- 02/11/21 RBC Capital
- General Motors price target raised to $67 from $52 at RBC Capital
- 11:54 Today RBC Capital
- Ovid downgraded to Sector Perform at RBC Capital after rally on Takeda deal
- 11:47 Today RBC Capital
- Ovid Therapeutics downgraded to Sector Perform from Outperform at RBC Capital
- 12/02/20 RBC Capital
- Ovid Therapeutics price target lowered to $5 from $17 at RBC Capital
- 12/02/20 Ladenburg
- Ovid Therapeutics price target lowered to $7 from $21 at Ladenburg
TAK Takeda Pharmaceutical - 11:54 Today RBC Capital
- Ovid downgraded to Sector Perform at RBC Capital after rally on Takeda deal
- 01/29/21 Morgan Stanley
- Morgan Stanley downgrades Jazz to Equal Weight ahead of competitor readout
- 12/29/20 Needham
- Needham names Phathom Pharmaceuticals Top Pick for 2021
- 12/15/20 Needham
- Phathom Pharmaceuticals price target raised to $55 from $45 at Needham
- 02/11/21 KeyBanc
- Uber price target raised to $75 from $63 at KeyBanc
- 02/11/21 Needham
- Needham transfers coverage on Lyft, raises price target $70 from $50
- 02/10/21 DA Davidson
- Lyft price target raised to $66 from $58 at DA Davidson
- 02/10/21 Jefferies
- Lyft price target raised to $75 from $70 at Jefferies
- 01/25/21 Roth Capital
- KemPharm initiated with a Buy at Roth Capital
- 05/20/20 H.C. Wainwright
- KemPharm price target lowered to $1.50 from $2.50 at H.C. Wainwright
- $41.77 /
-16.03 (-27.73%) - 13:34 Today Goldman Sachs
- Vir Biotechnology price target lowered to $59 from $61 at Goldman Sachs
- 11:37 Today H.C. Wainwright
- Vir Biotechnology selloff a 'terrific buying opportunity,' says H.C. Wainwright
- 02/25/21 Barclays
- Vir Biotechnology price target raised to $77 from $61 at Barclays
- 01/27/21 JPMorgan
- Vir Biotechnology added to analyst focus list as short idea at JPMorgan
- 15:29 Today Wells Fargo
- Wells Fargo lowers Wendy's target to $22 as current performance misses mark
- 02/26/21 Stephens
- Wendy's named Best Idea at Stephens
- 01/27/21
- Fly Intel: Top five analyst upgrades
- 01/27/21 Deutsche Bank
- Wendy's upgraded to Buy with $25 target at Deutsche Bank
- 07:36 Today
- Dollar Tree reports Q4 EPS $2.13, consensus $2.11
- 11/24/20
- Dollar Tree reports Q3 EPS $1.39, consensus $1.15
- 11/23/20
- Notable companies reporting before tomorrow's open
- 11/23/20
- Notable companies reporting before tomorrow's open
- 03/02/21
- Nordstrom sees FY21 revenue up more than 25%, consensus $13.46B
- 03/02/21
- Nordstrom reports Q4 EPS 21c, consensus 14c
- 03/02/21
- Nordstrom reports Q4 EPS 21c, consensus 14c
- 02/04/21
- Nordstrom gives long-term outlook, sees sales growing low single-digits annually
- 12/03/20
- Michaels sees Q4 sales up in the mid-single digits, consensus $1.82B
- 12/03/20
- Michaels reports Q3 adj. EPS 86c, consensus 59c
- 12/02/20
- Notable companies reporting before tomorrow's open
- 12/02/20
- Notable companies reporting before tomorrow's open
- 02/03/21
- Apollo Global reports Q4 fee related EPS 63c, consensus 50c
- 02/02/21
- Notable companies reporting before tomorrow's open
- 02/02/21
- Notable companies reporting before tomorrow's open
- 10/29/20
- Apollo Global reports Q3 fee-related EPS 63c, consensus 49c
- 01/27/21
- Las Vegas Sands reports Q4 adjusted EPS (37c), consensus (32c)
- 01/27/21
- Notable companies reporting after market close
- 10/21/20
- Las Vegas Sands reports Q3 adjusted EPS (67c), consensus (59c)
- 10/21/20
- Notable companies reporting after market close
- 02/18/21
- VICI Properties reports Q4 EPS 53c, consensus 48c
- 02/18/21
- VICI Properties sees FY21 AFFO per share $1.82-$1.87, consensus $1.88
- 02/18/21
- VICI Properties reports Q4 AFFO per share 46c, consensus 47c
- 10/28/20
- VICI Properties reports Q3 adjusted FFO 43c, consensus 42c
- 02/24/21
- Elanco raises FY21 adjusted EPS view to 90c-$1.00 from 83c-95c, consensus 91c
- 02/24/21
- Elanco sees Q1 adjusted EPS 20c-25, consensus 22c
- 02/24/21
- Elanco reports Q4 adjusted EPS 12c, consensus 9c
- 02/23/21
- Notable companies reporting before tomorrow's open
- 01/27/21
- Samsung sees overall profit weakening in Q1
- 01/27/21
- Samsung reports Q4 operating profit KRW9.05T
- 01/07/21
- Samsung sees Q4 operating profit KRW9.00T vs. KRW9.52T consensus
- 10/28/20
- Samsung reports Q3 operating profit KRW12.35T vs KRW7.78T last year
- 02/10/21
- General Motors sees FY21 EBIT-adjusted of $1.5B-$2B
- 02/10/21
- General Motors reports Q4 International EBIT-adjusted of $0.3B
- 02/10/21
- General Motors sees FY21 adjusted EPS $4.50-$5.25, consensus $5.89
- 02/10/21
- General Motors reports Q4 GM North America EBIT-adjusted of $2.6B
- 11/12/20
- Ovid Therapeutics reports Q3 EPS (28c), consensus (36c)
- 02/09/21
- Lyft reports Q4 revenue $569.9M, consensus $562.49M
- 02/09/21
- Notable companies reporting after market close
- 12/02/20
- Lyft sees Q4 sequential revenue growth at lower end of 11%-15% range
- 11/10/20
- Lyft reports Q3 adj. EPS (89c), consensus (91c)
- $41.77 /
-16.03 (-27.73%) - 11/10/20
- Vir Biotechnology reports Q3 EPS (67c), consensus (60c)
- 07:07 Today
- Wendy's sees FY21 adjusted EPS 67c-69c, consensus 72c
- 07:00 Today
- Wendy's reports Q4 adjusted EPS 17c, consensus 18c
- 11/04/20
- Wendy's reports Q3 adjusted EPS 19c, consensus 17c
- 11/03/20
- Notable companies reporting before tomorrow's open
|